Patients with low tumor tissue IL12B mRNA expression also had a significantly shorter RFS than those with high IL12B (HR = 0.69, 95% CI = 0.50–0.95, p = 0.021 for high vs. low expression). This evidence concerns the gene IL12B and neoplasm.